Evaluation of Anti-Factor Xa Level Usage for Low Molecular Weight Heparin in a Healthcare System
نویسندگان
چکیده
Background: Low-molecular-weight heparin (LMWH) is a commonly used anticoagulant for treatment of venous thromboembolism (VTE). Routine monitoring therapeutic effects through anti-Xa levels not recommended but may be beneficial in patients with altered pharmacokinetics.1,2 Inappropriate leads to excessive testing and premature dose adjustments, compromising safety efficacy. The purpose this project was assess appropriateness LMWH identify opportunities optimize utilization within community health system.
منابع مشابه
The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis.
Low molecular weight heparins (LMWHs) are now the mainstay option in the prevention and treatment of venous thromboembolism. In some patients receiving therapeutic doses of LMWH, activity can be measured by quantifying the presence of Anti-factor Xa (AFXa) for dose adjustment. However, currently there are no guidelines for LMWH monitoring in patients on thromboprophylactic, doses, despite certa...
متن کاملArguments against Monitoring Levels of Anti-Factor Xa in Conjunction with Low-Molecular-Weight Heparin Therapy
The product monographs for some low-molecular-weight heparins (LMWHs) state that anti-factor Xa concentrations should be monitored in the treatment of deep vein thrombosis. This article reviews the pharmacological and epidemiological basis for this recommendation and finds the evidence wanting. Anti-factor Xa activity varies for each LMWH, and evidence from clinical trials using anti-factor Xa ...
متن کاملLow Molecular Weight Heparin Overdose: A 10 Year Case Series
Background: Low molecular weight heparin (LMWH) is used for the treatment and prevention of coagulative disorders. Few patients receiving therapeutic doses of LMWH develop major hemorrhage. Currently there are few reports in the literature on acute overdose on adults. In this study, clinical profile, treatment and outcome of 21 patients who acutely overdosed enoxaparin are described. Method...
متن کاملAnti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability.
If laboratory monitoring of low molecular weight heparin (LMWH) therapy is required the test of choice is the anti Xa activity assay. The relationship between anti Xa results obtained using different techniques is unknown. The aim of the present study was to compare anti Xa results obtained with eight different commercially available anti Xa activity assays (five chromogenic and three clotting ...
متن کاملDevelopment of a fluorescent anti-factor Xa assay to monitor unfractionated and low molecular weight heparins.
Fluorogenic assays have many potential advantages over traditional clot-based and chromogenic assays such as the absence of interference from a range of factor deficiencies as well as offering the possibility of assays in platelet rich plasma or whole blood. A fluorogenic anti-factor Xa (anti-FXa) assay has been developed for the determination of unfractionated heparin (UFH), low molecular weig...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nursing & health sciences research journal
سال: 2022
ISSN: ['2578-3750']
DOI: https://doi.org/10.55481/2578-3750.1128